产品名称 | NebuSelect™ Recombinant Mouse CXCL13/BCA-1, hFc-tag |
---|---|
目录号 | NBL-242753 |
别名 | CXCL13/BCA-1; ANGIE; ANGIE2; BCA-1; BCA1; BLC; BLR1L; SCYB13 |
外观 | see COA |
分子量 | Ile22-Ala109 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O55038 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242753-100ug | 100ug | Inquire | Inquire | |
NBL-242753-1mg | 1mg | Inquire | Inquire | |
NBL-242753-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse CXCL13/BCA-1, hFc-tag
Catalog#:
NBL-242753
Description:
NebuSelect™ Recombinant Mouse CXCL13/BCA-1, hFc-tag(Cat#NBL-242753) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Ile22-Ala109.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 37.1 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
CXCL13/BCA-1; ANGIE; ANGIE2; BCA-1; BCA1; BLC; BLR1L; SCYB13
Target Information:
Recent studies have implicated chemokines in microglial activation and pathogenesis of neuropathic pain. C-X-C motif chemokine 13 (CXCL13) is a B lymphocyte chemoattractant that activates CXCR5. Using the spinal nerve ligation (SNL) model of neuropathic pain, CXCL13 was persistently upregulated in spinal cord neurons after SNL, resulting in spinal astrocyte activation via CXCR5 in mice.
Amino Acid Sequence:
Ile22-Ala109
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.